Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (INM)
NASDAQ:INM
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 4.94M | C$ 4.60M | C$ 4.14M | C$ 1.09M | C$ 0.00 |
| Gross Profit | C$ 1.71M | C$ 1.10M | C$ 1.40M | C$ 543.55K | C$ 0.00 |
| Operating Income | C$ -7.92M | C$ -8.13M | C$ -8.38M | C$ -13.79M | C$ -12.17M |
| EBITDA | C$ -7.26M | C$ -7.06M | C$ -7.78M | C$ -13.28M | C$ -12.17M |
| Net Income | C$ -8.16M | C$ -7.68M | C$ -7.95M | C$ -18.60M | C$ -12.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 15.09M | C$ 8.99M | C$ 11.81M | C$ 8.01M | C$ 9.16M |
| Total Assets | C$ 21.23M | C$ 16.17M | C$ 18.69M | C$ 16.46M | C$ 12.10M |
| Total Debt | C$ 1.01M | C$ 1.32M | C$ 518.92K | C$ 1.02M | C$ 333.64K |
| Net Debt | C$ -14.08M | C$ -7.67M | C$ -11.29M | C$ -6.93M | C$ -8.77M |
| Total Liabilities | C$ 2.92M | C$ 3.58M | C$ 2.67M | C$ 4.78M | C$ 2.97M |
| Stockholders' Equity | C$ 18.30M | C$ 12.59M | C$ 16.02M | C$ 11.69M | C$ 9.12M |
| Cash Flow | |||||
| Free Cash Flow | C$ -7.77M | C$ -7.00M | C$ -7.45M | C$ -15.62M | C$ -9.79M |
| Operating Cash Flow | C$ -7.77M | C$ -6.99M | C$ -7.28M | C$ -15.58M | C$ -9.79M |
| Investing Cash Flow | C$ 0.00 | C$ -9.29K | C$ -661.80K | C$ -673.00K | C$ -1.73K |
| Financing Cash Flow | C$ 12.27M | C$ 4.65M | C$ 10.68M | C$ 15.07M | C$ 10.85M |